Tong Guo
Direktor/Vorstandsmitglied bei CHINA HEALTH GROUP INC.
Aktive Positionen von Tong Guo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CHINA HEALTH GROUP INC. | Direktor/Vorstandsmitglied | 14.04.2023 | - |
| Independent Dir/Board Member | 14.04.2023 | - | |
Cali Biosciences Co. Ltd.
 Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - |
Karriereverlauf von Tong Guo
Ehemalige bekannte Positionen von Tong Guo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Gem Flower Pharmaceutical Science & Tech Beijing Co. Ltd. | Vorstandsvorsitzender | 01.09.2019 | 01.03.2021 |
| IQVIA RDS (Shanghai) Co. Ltd. | Corporate Officer/Principal | 01.05.2016 | 01.09.2019 |
| Wuxi Cds Clinical Research Shanghai Co. Ltd. | Corporate Officer/Principal | 01.01.2013 | 01.04.2015 |
Ausbildung von Tong Guo
| McGill University | Doctorate Degree |
Statistik
International
| China | 6 |
| Kanada | 2 |
Operativ
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHINA HEALTH GROUP INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| IQVIA RDS (Shanghai) Co. Ltd. | |
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Health Technology |
| Wuxi Cds Clinical Research Shanghai Co. Ltd. | |
| Gem Flower Pharmaceutical Science & Tech Beijing Co. Ltd. |
